mantle cell lymphoma

Showing 1 - 25 of 267

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Mantle Cell Lymphoma Trial in China (400mg of TQB3909 tablets, 600mg of TQB3909 tablets)

Recruiting
  • Mantle Cell Lymphoma
  • 400mg of TQB3909 tablets
  • 600mg of TQB3909 tablets
  • Beijing, Beijing, China
  • +27 more
Oct 26, 2023

Mantle Cell Lymphoma Trial in Duarte (drug, procedure, biological)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Not yet recruiting
  • Mantle Cell Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    Mantle Cell Lymphoma Trial in Miami, Houston (Zanubrutinib, Tafasitamab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Miami, Florida
    • +1 more
    Aug 31, 2023

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +13 more
    • (no location specified)
    Aug 29, 2023

    Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • +5 more
    • La Jolla, California
    • +7 more
    Aug 25, 2023

    Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

    Not yet recruiting
    • Lymphoma, B-Cell
    • +7 more
    • Adaptive Bridging Radiation Therapy (ABRT)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 16, 2023

    Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (Pirtobrutinib, LV20.19 CAR T cells)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • +5 more
    • (no location specified)
    Aug 4, 2023

    Mantle Cell Lymphoma Trial in China (High dose, Low dose)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • High dose
    • Low dose
    • Bengbu, Anhui, China
    • +20 more
    Jul 28, 2023

    Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Jul 26, 2023

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma Trial (FT596, Cyclophosphamide,

    Withdrawn
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • (no location specified)
    Jun 28, 2023

    Mantle Cell Lymphoma Trial in Hangzhou (LP-168 tablet)

    Recruiting
    • Mantle Cell Lymphoma
    • LP-168 tablet
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Jun 24, 2023

    Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

    Not yet recruiting
    • Hematologic Malignancy
    • +5 more
    • autologous hematopoietic stem cells added to planned CAR T
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 31, 2023

    Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

    Not yet recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +2 more
    • Biopsy
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    May 15, 2023

    Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    Apr 18, 2023

    Mantle Cell Lymphoma, MCL Trial in United States (Tafasitamab, Lenalidomide)

    Recruiting
    • Mantle Cell Lymphoma
    • MCL
    • Basking Ridge, New Jersey
    • +6 more
    Mar 27, 2023

    Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial (Brexucabtagene Autoleucel)

    Available
    • Mantle Cell Lymphoma
    • Acute Lymphoblastic Leukemia
    • Brexucabtagene Autoleucel
    • (no location specified)
    Mar 17, 2023

    Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +5 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 16, 2023

      Mantle Cell Lymphoma Trial in Worldwide (Bendamustine, Rituximab, Ibrutinib)

      Active, not recruiting
      • Mantle Cell Lymphoma
      • Tucson, Arizona
      • +201 more
      Jan 27, 2023

      Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

      Completed
      • Mantle Cell Lymphoma
      • Lymphoma, Mantle Cell
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jan 4, 2023

      Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +4 more
      • Tampa, Florida
        Moffitt Cancer Center
      Jan 12, 2023

      Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

      Recruiting
      • Follicular Lymphoma
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023